Basic aspects of Catechol-O-methyltransferase and the clinical applications of its inhibitors by Erkki Nissinen

Basic aspects of Catechol-O-methyltransferase and the clinical applications of its inhibitors

byErkki NissinenEditorErkki Nissinen

Hardcover | December 2, 2010

not yet rated|write a review

Pricing and Purchase Info

$301.10 online 
$365.06
Earn 1506 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Volume 95 ofInternational Review of Neurobiologyfocuses on Catechol-O-methyltransferase inhibition, and its clinical application in relation to Parkinson's disease. Chapters cover COMT gene and proteins, L-dopa treatment in Parkinson's disease, the latest research on COMT inhibitors and their clinical applications, as well as future prospects for their use.

  • Up-to-date summary of biochemistry and pharmacology of COMT and its inhibitors
  • Preclinical models in COMT inhibitor devlopment
  • Transgenic COMT mice - latest information summarized
  • Chemistry of COMT inhibitors and their design with molecular modelling
  • COMT gene and its regulation and relation to dopamine related diseases
  • Role of cofactor SAM regulation in relation to homocysteine
  • Nonclinical and clinical safety of COMT inhibitors summarized
  • Future prospects of COMT inhibitors in Parkinson's disease

Details & Specs

Title:Basic aspects of Catechol-O-methyltransferase and the clinical applications of its inhibitorsFormat:HardcoverDimensions:336 pages, 9 × 6 × 0.98 inPublished:December 2, 2010Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123813263

ISBN - 13:9780123813268

Look for similar items by category:

Customer Reviews of Basic aspects of Catechol-O-methyltransferase and the clinical applications of its inhibitors

Reviews

Extra Content

Table of Contents

  1. Introductory remarks: Catechol-O-methyltransferase inhibition: an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition
  2. Erkki Nissinen

  3. The catechol-O-methyltransferase gene, its regulation and polymorphisms
  4. Elizabeth M. Tunbridge

  5. Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?
  6. Timo T. Myöhänen & Pekka T. Männistö

  7. Catechol-O-methyltransferase enzyme: Cofactor S-adenosyl-L-methionine and related mechanisms
  8. Thomas Müller

  9. Biochemistry and pharmacology of catechol-O-methyltrasferase inhibitors
  10. Erkki Nissinen and Pekka T. Männistö

  11. The Chemistry of Catechol-O-methyltransferase Inhibitors
  12. David A. Learmonth, László E. Kiss and Patrício Soares-da-Silva

  13. Toxicology and safety of COMT inhibitors
  14. Kristiina Haasio

  15. Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of the L-dopa treatment
  16. Concepció Marin, J.A. Obeso

  17. Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease
  18. Seppo Kaakkola

  19. Catechol-O-methyltransferase and pain

Oleg Kambur & Pekka T. Männistö